Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of ECSP066627ApublicationCriticalpatent/ECSP066627A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
Se describen indazol-O-glucósidos sustituidos, composiciones que los contienen y métodos para usarlos, por ejemplo, para el tratamiento de diabetes y síndrome X.Indazol-O-substituted glycosides, compositions containing them and methods for using them are described, for example, for the treatment of diabetes and syndrome X.
Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
Compounds derived from substituted 4,5-dihydro-1h-pyrazol (4,3-g) benzothiazole; pharmaceutical composition; Useful for the treatment and prevention of cancer, infections, inflammatory and autoimmune diseases, among others.